about
Determining risk for severe leptospirosis by molecular analysis of environmental surface waters for pathogenic LeptospiraIvermectin versus albendazole or thiabendazole for Strongyloides stercoralis infectionIvermectin versus benzimidazoles for treating strongyloides infectionAzoles and ivermectin for treating strongyloides infectionClustered local transmission and asymptomatic Plasmodium falciparum and Plasmodium vivax malaria infections in a recently emerged, hypoendemic Peruvian Amazon communityVenezuelan Equine Encephalitis and Upper Gastrointestinal Bleeding in ChildFamily Aggregation of Human T-Lymphotropic Virus 1-Associated Diseases: A Systematic ReviewA scoping review of cost-effectiveness of screening and treatment for latent tubercolosis infection in migrants from high-incidence countriesBartonellosis. New and oldRapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled studyStrongyloides hyperinfection syndrome: an emerging global infectious diseaseSelf-reported risks for multiple-drug resistance among new tuberculosis cases: implications for drug susceptibility screening and treatmentHigh prevalence of primary multidrug resistant tuberculosis in persons with no known risk factorsQuinolone resistance in absence of selective pressure: the experience of a very remote community in the Amazon forestPrevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin-Mono-Resistant Pulmonary Tuberculosis in Lima, PeruMortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean.Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the CaribbeanHuman febrile illness caused by encephalomyocarditis virus infection, Peru
P50
Q21144700-F6AC5BDB-4946-4FD0-8BCD-AA94F4BCF994Q24186446-3FBD5495-F0D8-4692-B0D1-064BF8381E12Q24197775-F144D29D-B361-4590-B68C-99ACDD5BBC2FQ24240275-792D3CFD-6C1E-4C95-A05E-89A4E1EC5C5AQ24815742-49D0BFB1-6B20-4C75-8219-5BF7E163FF81Q27488231-77822F59-1F24-4517-8549-73987DC895C9Q28066384-22030201-5FC1-47A4-A02E-75BCF592D78FQ28081244-4BCEA5F1-6B03-44F9-9065-0BA3E62FB550Q28140078-FB9EFDD3-2670-4C1D-BB22-8170A01A9743Q28242324-262E5359-F502-4E26-836D-A309ED261122Q28271599-35407B5F-2244-4191-AF7A-36C515AF09A0Q28477499-4199EEFB-906E-4F25-B190-593C87C45271Q28477658-40C2E695-3C74-426A-9514-14B59B411157Q28482785-C40D9AAC-2A73-42BB-9927-90726B8E2860Q28551162-05305013-AAB0-4434-821E-1532F8C79670Q28647212-0F4D0A08-04D4-4ADB-9082-8CA81DA91E3DQ28749991-2FCC3F34-86CD-4E5F-9B59-626F5B2FA6E3Q28754683-D23CEEFF-254B-4D79-9DEC-8E6ACAAC85DC
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Eduardo Gotuzzo
@ast
Eduardo Gotuzzo
@en
Eduardo Gotuzzo
@es
Eduardo Gotuzzo
@nl
Eduardo Gotuzzo
@sl
type
label
Eduardo Gotuzzo
@ast
Eduardo Gotuzzo
@en
Eduardo Gotuzzo
@es
Eduardo Gotuzzo
@nl
Eduardo Gotuzzo
@sl
prefLabel
Eduardo Gotuzzo
@ast
Eduardo Gotuzzo
@en
Eduardo Gotuzzo
@es
Eduardo Gotuzzo
@nl
Eduardo Gotuzzo
@sl